Abstract
This study aimed to evaluate the effects of an ultra-diluted complex on the health status, growth performance, and blood parameters of dairy calves during the preweaning phase in a double-blind, placebo-controlled trial. During a 75-period trial, thirty-four Holstein newborn calves at the second day of life were completely randomized individually into two treatments: (1) control (CON), oral saline supplementation (5 mL/d); and (2) oral supplementation with 5 mL/d of a ultra-diluted complex (UD): Sulfur: 1060 + Viola tricolor: 1014 + Caladium seguinum: 1030 + Zincum oxydatum: 1030 + Phosphorus: 1060 + Cardus marianus: 1060 + Colibacillinum: 1030 + Podophyllum: 1030 + Vehicle: alcohol. Free access to water and a starter was ensured during the trial period. Feed intake and fecal and health scores were monitored daily. Calves were weighed and measured weekly. Blood samples were collected at enrollment on the first day and every 21 days until the 75th day, 2 h after morning milk feeding, and tested for hematology, blood urea nitrogen, aspartate aminotransferase, gamma-glutamyl transferase, total protein albumin, globulin, and creatinine. At 70 days of age, calves were disbudded following the standard management practices of the farm. The inflammatory profile, including Immunoglobulin A, Immunoglobulin G, ceruloplasmin, transferrin, albumin, and haptoglobin, was quantified in serum samples. The ultra-diluted complex was ineffective in reducing the incidence of diseases, starter feed intake, daily weight gain, and body measurements and inflammatory profile. Blood parameters were also not affected. Thus, the ultra-diluted complex was inefficient in reducing the incidence of diseases and did not affect the performance and metabolites of pre-weaned Holstein calves.